Suppr超能文献

基于 SEER 数据库的倾向评分匹配研究评估局部侵袭性胸腺瘤术后放疗的作用。

Evaluation of the role of postoperative radiotherapy in locally invasive thymoma: A propensity-matched study based on the SEER database.

机构信息

Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.

出版信息

PLoS One. 2023 Apr 13;18(4):e0283192. doi: 10.1371/journal.pone.0283192. eCollection 2023.

Abstract

OBJECTIVES

No consensus was reached on the efficacy of postoperative radiotherapy (PORT) in locally invasive thymomas because of the rarity of the thymic epithelial and the variations of study results. Therefore, we aimed to explore the efficacy of PORT in locally invasive thymomas using the Surveillance, Epidemiology, and End Results (SEER) database.

METHODS

Patients diagnosed with thymomas from 2004 to 2016 were identified using the SEER database. Prognostic factors of cancer-specific survival (CSS) and overall survival (OS) were identified using univariate and multivariate Cox regression analyses.Propensity score matching (PSM) was performed to balance the baseline characteristics.

RESULTS

A total of 700 eligible patients were identified. After PSM, 262 paired patients were selected from the two groups, those who received or did not receive PORT. Receiving PORT improved CSS and OS before and after PSM. In the matched population, the multivariate analyses showed that tumour invasion into adjacent organs/structures and non-utilisation of PORT were independent poor prognostic factors for CSS, whereas age ≥62 years,tumour invasion into adjacent organs/structures, and non-utilisation of PORT were independently associated with poorer OS. The subgroup analysis revealed that PORT improved CSS and OS in Masaoka-Koga stage III thymoma, but showed no OS benefit in Masaoka-Koga stage IIB thymoma.

CONCLUSION

Based on the SEER database, we found that PORT provides a significant survival benefit in Masaoka-Koga stage III thymoma with complete or incomplete resection. The role of PORT in thymoma requires further evaluation.

摘要

目的

由于胸腺癌上皮组织罕见且研究结果存在差异,因此对于局部侵袭性胸腺瘤术后放疗(PORT)的疗效尚未达成共识。因此,我们旨在利用监测、流行病学和最终结果(SEER)数据库探讨 PORT 在局部侵袭性胸腺瘤中的疗效。

方法

使用 SEER 数据库确定 2004 年至 2016 年间诊断为胸腺瘤的患者。使用单变量和多变量 Cox 回归分析确定癌症特异性生存(CSS)和总生存(OS)的预后因素。进行倾向评分匹配(PSM)以平衡基线特征。

结果

共纳入 700 例符合条件的患者。PSM 后,从两组中选择了 262 对匹配患者,一组接受 PORT,另一组未接受 PORT。接受 PORT 可改善 PSM 前后的 CSS 和 OS。在匹配人群中,多变量分析表明肿瘤侵犯相邻器官/结构和未使用 PORT 是 CSS 的独立不良预后因素,而年龄≥62 岁、肿瘤侵犯相邻器官/结构和未使用 PORT 与较差的 OS 独立相关。亚组分析显示,PORT 可改善 Masaoka-Koga 分期 III 期胸腺瘤的 CSS 和 OS,但在 Masaoka-Koga 分期 IIB 胸腺瘤中未显示 OS 获益。

结论

基于 SEER 数据库,我们发现对于完全或不完全切除的 Masaoka-Koga 分期 III 期胸腺瘤,PORT 提供了显著的生存获益。PORT 在胸腺瘤中的作用需要进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd33/10101529/8687887e5272/pone.0283192.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验